AIIMS Validates Indigenous Stroke Device Matching International Standards in Clinical Trial

AIIMS leads a clinical trial of India’s first homegrown stroke device, reporting that the device’s performance matches that of leading imported alternatives in restoring blood flow for patients with acute ischemic stroke, confirming its clinical effectiveness.

Device was developed by Indian engineers and clinicians to provide a low‑cost, locally manufactured solution, featuring a self‑expanding mesh that can be delivered through a catheter to the blocked brain artery, simplifying the procedure for physicians.

Trial results showed comparable safety, similar rates of successful reperfusion, and no increase in adverse events, giving researchers confidence that the indigenous device can be used widely across Indian hospitals and potentially in regional centers.

Implications include a potential reduction in import dependence, lower treatment costs for stroke patients, and alignment with national “Make in India” goals, signaling a step forward for domestic medical‑device innovation and encouraging further research investment.